A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors
| Image |  |
|---|---|
| Description | scientific article published on November 8, 2010 |
| Author/s |
author: Richard Aplenc Frank Balis |
| Publication date | November 8, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work |
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.9674?role=tab |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |